Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Prof Jonathan Rees will take up the leadership role on 1 April.

Horizontal portrait of Jonathan Rees

Professor Jonathan Rees is the Director of the Botnar Institute for Musculoskeletal Sciences at the University of Oxford and is Honorary Consultant Orthopaedic Shoulder Surgeon at the Nuffield Orthopaedic Centre.  



I am honoured to be taking over the Headship of NDORMS from Professor Andy Carr. Over the last 20 years Andy has steered the department to its position as an internationally renowned musculoskeletal research and teaching department. I look forward to working closely with all our staff and students to deliver world class research and new discoveries to improve the lives of people suffering with musculoskeletal pain and disability.
Professor Jonathan Rees


Professor Andrew Carr will step down at the end of March as NDORMS Head of Department after 21 years. During that time he has realised a vision, alongside the comprehensive rebuild of the Nuffield Orthopaedic Centre Hospital (NOC), to construct the three wings of Botnar Research Institute on the hospital site, and the move of the Kennedy Institute for Rheumatology to Oxford, bringing world leading research hand-in-hand with NHS patient care.

Professor Gavin Screaton, Head of the Medical Sciences Division commented: “I would like to take this opportunity to thank Andy for his 21 years of service to the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, and welcome Professor Jonathan Rees as the new Head of Department.  

Under Andy’s tenure, NDORMS has grown significantly from 20 to over 500 research staff and students. His research in defining the use of the Oxford Knee as a partial knee replacement and the development of Oxford Score to assess patients’ views of surgical outcomes has been hugely impactful to millions of patients across the world. He has also been instrumental in pioneering the use of randomised clinical trials of surgery to improve evidence for commonly performed operations. I wish Andy continued success in the new phase of his career. 

Jonathan takes over leadership of the Department at an exciting time, with the recent opening of the Marcela Botnar wing. The new wing will house a cohort of bioengineers, all researching ways to improve the treatment of arthritis, osteoporosis and other bone and joint diseases. I wish Jonathan every success in these new endeavours and look forward to hearing more good news from the Department.”

Professor Andrew Carr, current Head of Department said: “It is wonderful to hear that Professor Jonny Rees will be taking on the headship of NDORMS in April this year. I have no doubt that he will provide huge energy and inspirational leadership in the role and I wish him every success.” 

Prof Rees profile

Graduating from St Mary's Hospital Medical School, London, Prof Rees then trained in orthopaedic surgery in Oxford. He was appointed Clinical Lecturer to NDORMS in 2004 and then University Lecturer in 2005. He continued as a consultant shoulder and elbow surgeon, while teaching, training and running a musculoskeletal research programme before becoming Professor of Orthopaedic Surgery and Musculoskeletal Science in 2014. He has a number of national roles including President of the British Elbow and Shoulder Society, and is an NIHR Senior Investigator. Besides his University and national work, he continues to work as a Consultant Orthopaedic Shoulder Surgeon at the Nuffield Orthopaedic Centre


Similar stories

Adalimumab is found to be a cost-effective treatment for early-stage Dupuytren’s disease

Researchers at the Kennedy Institute of Rheumatology and Oxford Population Health’s Health Economics Research Centre have found that anti-TNF treatment (adalimumab) is likely to be a cost-effective treatment for people affected by early-stage Dupuytren’s disease.

Patients like me

What can patients learn from the experiences of people like them who’ve already had a hip replacement? A new tool called ‘Patients like me’ helps answer some of the questions about pain, complications and how long the prosthesis might last.

Study reveals new evidence on rare blood-clotting condition after covid-19 vaccination

Researchers from NDORMS at the University of Oxford have investigated claims that some adenovirus-based COVID-19 vaccines increase the risk of rare blood clots compared to their mRNA-based counterparts.

NDORMS contributes to new UK research to tackle monkeypox outbreak

The UK’s efforts to tackle the monkeypox outbreak will receive a huge boost with the creation of a new research consortium and a new study to study vaccine effectiveness.

World Osteoporosis Day 2022

A bone-healthy lifestyle is vital for strong bones and a mobile, fracture-free future. On World Osteoporosis Day, we are sharing advice from the International Osteoporosis Foundation (IOF), on putting your bone health first.

Mathematician boosts data science research at the Kennedy Institute

Welcome to Yang Luo who has joined the Kennedy Institute as the Principal Investigator of the Luo Group. Her lab is leading the investigation into how genetic variations contribute to diseases of the immune system.